# A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)

> **NCT00004845** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute on Aging (NIA)**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Rofecoxib
- **DRUG:** Naproxen

## Key facts

- **NCT ID:** NCT00004845
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** — (—)
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004845, "A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00004845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*